Q & M Dental Group (Singapore) Ltd
SGX:QC7
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Price:
0.545
SGD
2.83%
Market Cap:
S$526.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
SG |
|
J
|
Jolimark Holdings Ltd
HKEX:2028
|
HK |
|
M
|
Malee Group PCL
SET:MALEE
|
TH |
|
C
|
CSD Water Service Co Ltd
SSE:603903
|
CN |
|
T
|
Tatia Global Vennture Ltd
BSE:521228
|
IN |
|
P
|
Plug Power Inc
XETRA:PLUN
|
US |
|
Huafa Property Services Group Co Ltd
HKEX:982
|
HK |
|
A
|
Allied Machinery Co Ltd
SSE:605060
|
CN |
|
Investor AB
STO:INVE A
|
SE |
|
Coca-Cola Bottlers Japan Holdings Inc
TSE:2579
|
JP |
|
Minebea Mitsumi Inc
TSE:6479
|
JP |
|
A
|
Alphabet Inc
MIL:GOOG
|
US |
|
Hazer Group Ltd
ASX:HZR
|
AU |
|
Pasona Group Inc
TSE:2168
|
JP |
|
Avangrid Inc
NYSE:AGR
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Q & M Dental Group (Singapore) Ltd (QC7)
under the Base Case is
hidden
SGD.
Compared with the current market price of 0.545 SGD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QC7 Multiples-Based Value
LOCKED
Multiples Across Competitors
QC7 Competitors Multiples
Q & M Dental Group (Singapore) Ltd Competitors
Q & M Dental Group (Singapore) Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SG |
|
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
514.7m SGD | 2.6 | 55.3 | 13.5 | 25.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
93.4B USD | 0.2 | 52.8 | 13.7 | 13.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.2B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
71.1B USD | 0.3 | 11.9 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.5B EUR | 1.1 | 19.4 | 9.2 | 13.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 1.1 | 23 | 8.9 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 1.6 | 25.6 | 12.3 | 17.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2 | 22 | 11.9 | 16.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.3B USD | 12.5 | -29.4 | -32.2 | -29.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 13.4 | 7 | 9.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
